股票代码：600160 股票简称：巨化股份 公告编号：临 2023-36 浙江巨化股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 （截止 2023 年 6 月 30 日） 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》（证监 会公告〔2022〕15 号和《上海证券交易所上市公司自律监管指引第 1 号——规范运作》（上 证发〔2022〕2 号）及相关格式指引的要求，浙江巨化股份有限公司（以下简称"公司"）编 制了 2023 年半年度募集资金存放与实际使用情况专项报告，内容如下： 一、募集资金基本情况 (一) 实际募集资金金额和资金到账时间 根据公司六届二十一次董事会和 2015 年第二次临时股东大会决议，并经中国证券监督 管理委员会《关于核准浙江巨化股份有限公司非公开发行股票的批复》（证监许可〔2016〕 504 号）核准，公司和主承销商浙商证券股份有限公司确定向 4 名特定投资者非公开发行人 民币普通股（A 股）股票 300,7 ...

股票代码：600160 股票简称：巨化股份 公告编号：临 2023-34 浙江巨化股份有限公司 详见上海证券交易所网站 www.sse.com.cn：本公司临 2023－36 号公告《浙 江巨化股份有限公司 2023 半年度募集资金存放与使用情况的专项报告》。 四、以 12 票同意、0 票反对、0 票弃权，通过《浙江巨化股份有限公司发展 规划（2023-2027 年）》 董事会九届四次（通讯方式）会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）董事会于 2023 年 8 月 14 日以 电子邮件、书面送达等方式向公司董事发出召开董事会九届四次会议（以下简称 "会议"）的通知。会议于 2023 年 8 月 24 日以通讯方式召开。会议应出席董事 12 人，实际出席 12 人。会议的召开符合有关法律、行政法规、部门规章、规范 性文件和公司章程的规定。与会董事经认真审议后，做出如下决议： 一、以 12 票同意、0 票反对、0 票弃权，通过《公司 2023 年半年度报告及 摘 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2023 年 9 月 1 日(星期五) 上午 09:00-10:00 股票代码：600160 票简称：巨化股份 公告编号：临 2023-37 浙江巨化股份有限公司 关于召开 2023 年半年度业绩说明会的公告 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 8 月 25 日(星期五) 至 8 月 31 日(星期四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司信箱 zhuli@juhua.com 向公司提问，公司将在本次说明会上就投资者普遍关注的问题 进行回答。 浙江巨化股份有限公司（以下简称"公司"）已于 2023 年 8 月 25 日披露《公 司 2023 年半年度报告》，为便于广大投资者更全面深入地了解公司 2023 年半年 度经营成果、财务状况等情况。公司计划于 2023 年 9 月 1 日 ...

浙江巨化股份有限公司 关于巨化集团财务有限责任公司2023年半年度风险评估报告 （截止2023年6月30日） 根据《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管 指引第5号——交易与关联交易》及公司《巨化股份在巨化集团财务有限责任公 司存款风险应急管理办法》的有关要求，浙江巨化股份有限公司（以下简称 "本公司"或"公司"）通过查验是否具有有效的《金融许可证》、《企业法 人营业执照》；取得并审阅包括资产负债表、利润表、现金流量表、所有者权 益变动表等在内的定期财务报告，评估本公司之关联方——巨化集团财务有限 责任公司（以下简称"财务公司"）的经营资质、业务与财务风险。 具体风险评估情况如下： 一、财务公司基本情况 财务公司是经银监会浙江监管局浙银监复[2014]79号文批准，由巨化集团 有限公司（出资比例50%）、浙江巨化股份有限公司（出资比例40%）、巨化衢 州公用有限公司（出资比例10%）共同出资组建的一家非银行金融机构，2014年 2月14日取得银监会浙江监管局颁发的金融许可证（机构编码： L0190H233080001），2023年3月3日中国银行保险监管理委员会浙江监管局换发 新的《金 ...

股票简称：巨化股份 股票代码：600160 公告编号：临 2023－35 浙江巨化股份有限公司 监事会九届四次（通讯方式）会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）监事会于2023年8月14日以电 子邮件、书面送达等方式向公司监事发出召开监事会九届四次会议（以下简称 "会议"）的通知。会议于2023年8月24日以通讯方式召开。会议应出席监事3 人，实际出席监事3人。会议的召集、召开符合有关法律、行政法规、部门规 章、规范性文件和公司章程的规定。与会监事经认真审议后，做出如下决议： 二、以 3 票同意、0 票反对、0 票弃权，通过《2023 半年度募集资金存放与 使用情况的专项报告》 截至 2022 年 6 月 30 日止，公司对募集资金进行了专户存放和专项使用。 公司不存在变相改变募集资金用途和损害股东利益的情况，不存在违规使用 募集资金的情形。公司募集资金的存放与实际使用情况,以及变更部分募集资金 项目，符合《证券法》，中国证监会、上海证券交易所有关上市公司募 ...

浙江巨化股份有限公司独立董事关于 | 张子学 | 刘 | 力 | 鲁桂华 | 王玉涛 | | --- | --- | --- | --- | --- | | _________ | __________ | | __________ | _________ | 签署日期：2023 年 8 月 24 日 作为浙江巨化股份有限公司（以下简称"公司"）的独立董事，我们根据《上 海证券交易所股票上市规则》和《公司章程》等有关规定，对巨化集团财务有限 责任公司 2023 年半年度存款风险评估报告发表如下独立意见： 公司董事会九届四次会议审议和表决本项议案的程序符合《上海证券交易所 股票上市规则》《上海证券交易所上市公司自律监管指引第 5 号——交易与关联 交易》及《公司章程》等有关规定，关联董事回避了对本项议案的表决。我们认 真审阅了《关于巨化集团财务有限责任公司 2023 年半年度存款风险评估报告》 及相关材料，认为：巨化集团财务有限责任公司具有合法有效的《金融许可证》、 《企业法人营业执照》，未发现其财务指标不符合《企业集团财务公司管理办法》 规定的要求，其经营行为存在违反国家金融监督管理总局颁布的相关规定的情形， ...

中巨芯科技股份有限公司 首次公开发行股票并在科创板上市招股意向书附录 | 序号 | 文件名称 | 页码 | | --- | --- | --- | | 1 | 发行保荐书 | 1 | | 2 | 法律意见书 | 34 | | 3 | 律师工作报告 | 450 | | 4 | 财务报告及审计报告 | 607 | | 5 | 发行人审计报告基准日至招股说明书签署日之间的相关财务报表 及审阅报告 | 748 | | 6 | 内部控制鉴证报告 | 773 | | 7 | 经注册会计师鉴证的非经常性损益明细表 | 787 | | 8 | 公司章程（草案） | 801 | | 9 | 关于同意中巨芯科技股份有限公司首次公开发行股票注册的批复 | 847 | 海通证券股份有限公司 关于中巨芯科技股份有限公司 首次公开发行股票并在科创板上市 之 发行保荐书 保荐人（主承销商） （上海市广东路 689 号） 二〇二三年六月 声 明 本保荐人及保荐代表人根据《中华人民共和国公司法》（下称"《公司法》"）、 《中华人民共和国证券法》（下称"《证券法》"）、《证券发行上市保荐业务管理 办法》（下称"《保荐管理办法》"）、《首次公开发 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 4,576,422,409.87, a decrease of 0.68% compared to the same period last year[6]. - Net profit attributable to shareholders was CNY 152,603,797.97, down 34.89% year-on-year[6]. - The net profit after deducting non-recurring gains and losses was CNY 131,937,256.26, reflecting a decline of 40.55%[6]. - Basic and diluted earnings per share were both CNY 0.057, down 34.48% compared to the previous year[7]. - Net profit for Q1 2023 was CNY 143,151,232.93, down 39.5% from CNY 236,919,126.69 in Q1 2022[18]. - The company reported a decrease in comprehensive income to CNY 142,722,054.12 from CNY 236,355,791.99 in the same quarter last year[18]. Cash Flow - The net cash flow from operating activities was CNY 256,794,141.08, a decrease of 36.31% due to increased tax payments in Q1[8]. - The net cash flow from operating activities decreased to approximately $256.79 million in Q1 2023, down from $403.18 million in Q1 2022, reflecting a decline of about 36.4%[20]. - The cash inflow from financing activities was approximately $90 million in Q1 2023, down from $220 million in Q1 2022, indicating a decrease of about 59.1%[21]. - The net cash flow from financing activities was approximately $17.26 million in Q1 2023, a decrease from $31.86 million in Q1 2022, reflecting a decline of about 45.0%[21]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 22,815,383,584.75, an increase of 0.83% from the end of the previous year[7]. - Total liabilities as of Q1 2023 were CNY 6,879,491,299.75, a slight increase from CNY 6,842,255,673.14 in the previous year[17]. - The company’s total assets reached CNY 22,815,383,584.75, compared to CNY 22,626,691,196.94 in Q1 2022[17]. Shareholder Information - Shareholder equity attributable to the parent company was CNY 15,629,295,324.78, up 1.04% from the previous year-end[7]. - The total number of ordinary shareholders at the end of the reporting period was 56,556[10]. Investment and Expenses - The company reported an increase in investment income to CNY 31,757,396.42, significantly higher than CNY 8,392,683.42 in the previous year[17]. - Research and development expenses decreased to CNY 247,497,852.55, down 31.2% from CNY 360,072,298.65 in Q1 2022[17]. - The company reported non-recurring gains of CNY 20,666,541.71, primarily from asset disposals and government subsidies[8]. Current Assets - As of March 31, 2023, total current assets amounted to RMB 7,582,602,652.23, a decrease from RMB 7,829,719,089.18 as of December 31, 2022, reflecting a decline of approximately 3.16%[12]. - The company's cash and cash equivalents decreased to RMB 2,259,033,242.29 from RMB 2,547,268,714.78, representing a decline of about 11.32%[12]. - Accounts receivable increased to RMB 1,030,696,245.36 from RMB 980,426,719.78, indicating an increase of approximately 5.12%[12]. - Inventory rose to RMB 1,826,647,089.00 from RMB 1,727,638,439.83, marking an increase of around 5.74%[12]. - The company reported a significant increase in prepayments, rising to RMB 272,682,314.97 from RMB 76,824,329.49, which is an increase of approximately 254.09%[12]. Operating Costs - Total operating costs increased to CNY 4,443,207,408.79, up 3.12% from CNY 4,308,985,170.05 in the same period last year[17].

股票代码：600160 股票简称：巨化股份 公告编号：临 2023-28 浙江巨化股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： http://roadshow.sseinfo.com） 会议召开方式：上证路演中心网络互动 问题征集方式：投资者可于 2023 年 5 月 11 日(星期四)至 5 月 17 日 (星期三)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过 公司信箱 zhuli@juhua.com 向公司提问，公司将在本次说明会上就投资者普遍 关注的问题进行回答。 浙江巨化股份有限公司（以下简称"公司"）已于 2023 年 4 月 21 日披露《公 司 2022 年年度报告》，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况等情况。公司计划于 2023 年 5 月 18 日（星期四）下午 15:00-16:00 通过网络互动方式召开业绩说明会，与广大投资者进行充分交流，解答投资者普 遍关注的问题。 ...

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the fiscal year 2022, representing a growth of 15% compared to the previous year[25]. - The company's operating revenue for 2022 was CNY 21,489,124,417.71, representing a 19.48% increase compared to CNY 17,985,585,441.93 in 2021[26]. - The net profit attributable to shareholders for 2022 reached CNY 2,380,732,575.42, a significant increase of 114.66% from CNY 1,109,093,339.47 in 2021[26]. - The basic earnings per share for 2022 was CNY 0.88, an increase of 114.63% compared to CNY 0.41 in 2021[27]. - The company achieved operating revenue of 21.489 billion yuan, a year-on-year increase of 19.48%, marking the first time revenue exceeded 20 billion yuan[33]. - The total profit for the reporting period was 2.72533 billion yuan, an increase of 164.954 million yuan year-on-year[38]. - The company reported a quarterly revenue of CNY 5,112,174,525.36 in Q4 2022, with a net profit of CNY 681,840,133.70 for the same period[28]. Market Expansion and Strategy - The company plans to expand its market presence in Asia, targeting a 10% market share by 2025[11]. - Future guidance suggests a projected revenue growth of 15% for the next fiscal year, driven by market expansion and new technology adoption[11]. - The company is focusing on market expansion in Southeast Asia, targeting a 25% increase in market share within the next two years[25]. - The company plans to continue expanding its market presence and investing in new product development to sustain growth[91]. - The company is actively pursuing strategic partnerships and acquisitions to bolster its research and development capabilities in advanced fluorinated materials[16]. Research and Development - The company is investing $50 million in R&D for developing eco-friendly refrigerants, aiming to reduce greenhouse gas emissions by 25% over the next five years[11]. - The company completed R&D investments of 824 million RMB, focusing on advanced fluorinated materials and green refrigerants[168]. - A total of 131 R&D projects were implemented, resulting in 31 major outcomes, including 15 small-scale, 8 pilot-scale, and 8 industrialization results[169]. - The company has received 91 patent authorizations and filed 76 patent applications, enhancing its technological innovation capabilities[42]. Sustainability and Environmental Initiatives - The company has implemented a new strategy focusing on sustainability, aiming for a 50% reduction in carbon footprint by 2030[11]. - The company is committed to sustainability initiatives, aiming for a J% reduction in carbon emissions by the end of the fiscal year[12]. - The company is focusing on green low-carbon operations, with 40.32MW distributed photovoltaic projects and 5,050,000 kWh of green electricity traded[45]. - The company is committed to promoting clean energy applications and increasing the proportion of non-fossil energy utilization in the industrial sector[117]. Operational Efficiency and Cost Management - The gross profit margin improved to 35%, up from 30% last year, due to cost optimization measures[11]. - The company maintained a focus on safety and environmental responsibility, aiming for "zero violations, zero hazards, and zero accidents" in production[34]. - The company emphasized market expansion and product structure optimization to enhance operational efficiency and profitability[38]. - The company has established partnerships with three major distributors to strengthen its supply chain and distribution network[25]. Challenges and Risks - The company faced challenges in 2022 due to weak global economic growth and increased market competition, impacting its operational stability[32]. - The company faced cost pressures from rising raw material prices, which reduced profits by 1.00734 billion yuan[40]. - The company closely monitors industry policy changes to adapt its management activities and long-term development strategies[112]. Product Development and Innovation - The company reported a significant range of applications for PTFE, including pipes, rods, sheets, and various insulation materials, indicating a broad market presence[14]. - The introduction of new products, including various blends of refrigerants like R404A and R410A, is expected to enhance market competitiveness and meet regulatory standards[13]. - The company is focusing on high-performance polymer materials, moving towards product upgrades and application development in response to market demands[151]. - The company is actively developing a series of electronic fluorinated liquids, enhancing its competitive edge in the refrigerant market[146]. Financial Health and Investments - The net cash flow from operating activities for 2022 was CNY 3,316,621,737.56, up 165.90% from CNY 1,247,330,731.61 in 2021[26]. - The company's monetary funds at the end of the period amounted to CNY 2,547.27 million, representing 11.26% of total assets, a 65.53% increase from the previous year[106]. - The company has invested 50 million CNY in R&D for new technologies aimed at improving production efficiency[25]. - The company has a strong market presence in East and South China, with its main products having significant influence in Zhejiang and surrounding areas[84].